Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Neurology
Biotech
Trace uses $101M series A to go after same ALS target as Lilly
Trace Medicine has launched with $101 million and a mission to treat ALS by targeting a protein that recently caught Lilly's attention
James Waldron
Nov 12, 2024 7:00am
Eisai plants molecular glue SEED with $1.5B biobucks deal
Aug 6, 2024 10:24am
Roche pays Ascidian $42M to develop RNA exon editing drugs
Jun 18, 2024 7:00am
Labcorp, Quest add new blood tests for Alzheimer's, brain damage
Apr 22, 2024 2:17pm
Roche, pipeline bulging from deal spree, axes 8 programs
Feb 1, 2024 7:32am
RapidAI earns FDA nod for subdural hematoma-spotting AI
Nov 10, 2023 10:06am
